Seractiv

Quick links to important sections

Seractiv

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Seractiv

Seractiv: Defining the Chemical Identity and Pharmaceutical Class

Seractiv is a medicinal entity whose active substance is Dexibuprofen, chemically defined as the S(+)-Ibuprofen enantiomer. This medication belongs to the Non-steroidal Anti-inflammatory Drug (NSAID) pharmacological class. The purpose of this class of synthetic drugs is to alleviate discomfort, reduce fever, and modulate the biological process of inflammation. The specific brand, Seractiv, is typically classified as a prescription-only (Rx) product, indicating the necessity of professional consultation for its use.

The S-enantiomer, or eutomer, is the component responsible for the therapeutic activity, distinguishing it from the racemic Ibuprofen mixture. This isolated enantiomer is used for the symptomatic relief of various conditions.

The Targeted Composition and Origin of Dexibuprofen

The composition of Seractiv is characterized as a single-ingredient product featuring the refined Dexibuprofen molecule. Dexibuprofen is produced through a chiral switch, a process that isolates the active S-enantiomer from the R-enantiomer present in standard Ibuprofen. This synthetic small molecule is formulated for the oral route of administration and is typically presented as film-coated tablets, capsules, or powder for oral suspension. The use of the S(+)-Ibuprofen enantiomer is the primary compositional feature used in the management of inflammatory pain.

General Purpose: How Seractiv Modulates Pain and Inflammation

The medicine's general purpose is achieved through its function as a cyclooxygenase (COX) inhibitor. By binding to and blocking the COX enzymes, the drug limits the body's synthesis of prostaglandins, which are the lipid compounds that act as messengers for pain, fever, and swelling. This biochemical intervention allows Seractiv to modulate the inflammatory response, such as easing the discomfort associated with muscle strains and similar inflammatory conditions.

What side effects are possible with Seractiv?

Possible Side Effects and Safety Information

The safety profile of Seractiv (Dexibuprofen), an NSAID, is characterized by adverse reactions officially classified by frequency and grouped by the affected organ system, consistent with regulatory documentation.

Adverse Reaction Classification

Classification Tier Affected Systems/Examples Official Frequency
Common Reactions Gastrointestinal System (e.g., nausea, indigestion, abdominal pain), Nervous System (e.g., headache, dizziness) ge 1/100 to < 1/10
Uncommon Reactions Gastrointestinal System (e.g., abdominal cramps), Nervous System (e.g., nervousness) ge 1/1,000 to < 1/100
Rare Reactions Dermatological (e.g., severe skin reactions), Allergic (e.g., anaphylaxis), Renal/Hepatic Impairment ge 1/10,000 to < 1/1,000

Serious Adverse Reactions and Safety Constraints

Official regulatory documents emphasize the potential for serious adverse reactions. These include severe gastrointestinal events such as bleeding, ulceration, and perforation, which may be fatal and can occur without prior warning. There is also an officially documented risk of serious cardiovascular thrombotic events, including myocardial infarction and stroke.

Safety constraints and temporal patterns are explicitly documented. The risk of serious cardiovascular events is associated with high daily doses and may increase with the duration of use. Furthermore, regulatory information notes that the elderly population faces a greater risk for adverse effects, particularly severe gastrointestinal complications. For safety reasons, the use of this medicine is restricted in the setting of coronary artery bypass graft (CABG) surgery and is contraindicated during the third trimester of pregnancy due to potential fetal toxicity.

Overdose and Emergency Response

Overdose with the active substance, Dexibuprofen, is officially documented to present with various clinical manifestations across multiple systems. Initial signs commonly include gastrointestinal effects such as nausea, vomiting, and abdominal pain, alongside central nervous system symptoms like drowsiness, headache, and tinnitus.

In instances of severe exposure, regulatory documents emphasize the potential for life-threatening outcomes. These severe manifestations include acute renal failure, significant gastrointestinal bleeding or perforation, severe hypotension, and neurological effects such as seizures and coma. Elderly patients are specifically noted as a population with an increased risk for these severe adverse reactions.

Immediate medical action is mandated when overdose is suspected. Government guidance explicitly states to seek immediate medical attention and contact emergency services without delay, particularly if signs of severe systemic toxicity are observed, such as difficulty breathing or slurred speech.

Official labeling confirms that no specific antidote is known for Dexibuprofen overdose. Therefore, management is defined as providing symptomatic and supportive treatment, which may require monitoring of vital signs, ECG, and laboratory parameters in a hospital setting.

Therapeutic Uses of Seractiv

Seractiv is commonly used across conditions characterized by periods of heightened symptoms, applying to domains where additional symptomatic support is needed. The medication is generally classified as a non-steroidal anti-inflammatory drug (NSAID) used to address pain and inflammation.

This medicine is relevant for easing symptoms related to inflammatory or irritative processes, including discomfort, stiffness, and swelling associated with conditions like osteoarthritis and certain phases of rheumatoid arthritis. It is also commonly used when short-term symptomatic assistance is needed for acute and episodic manifestations such as menstrual cramps, sharp toothache, and discomfort following minor surgical or dental procedures. Furthermore, it is applied in contexts involving heightened systemic burden, specifically for easing elevated body temperature, or fever, associated with common illnesses.

“Applied in clinical settings that involve acute or unstable symptom patterns, this medicine supports the patient during difficult episodes by easing distress.”

Quick Fact: Symptomatic Support for Inflammatory Discomfort

Seractiv plays a role in managing symptom clusters that create noticeable physiological strain, helping to improve day-to-day comfort and assisting with maintaining functional stability when symptoms interfere with routine activities.

Regulatory References

  1. European Medicines Agency (EMA) review

Eligibility and Restrictions for Use

Who Can and Cannot Use Seractiv?

The population eligibility for Seractiv (Dexibuprofen) is strictly defined by official regulatory documentation detailing absolute prohibitions and conditional restrictions.


Contraindicated Populations

Use is prohibited for patients with known hypersensitivity to the drug, or any other NSAID, particularly if NSAIDs have previously triggered asthma, bronchospasm, or angioedema. The medicine is contraindicated for individuals with severe heart failure, severe renal dysfunction (GFR < 30 ml/min), or severely impaired hepatic function. Further, the drug must not be used by patients with active or recurrent peptic ulcer/haemorrhage, active gastrointestinal bleeding, or active Crohn's disease/ulcerative colitis.

Age and Condition Restrictions

Seractiv is generally established for adults (18 years and older). The medicine is not recommended for children and adolescents as safety and efficacy have not been sufficiently established in these age groups. Use is absolutely contraindicated in pregnancy from the third trimester (20 weeks gestation onward) due to fetal risks. Women attempting to conceive are a restricted-use population due to the drug’s potential to reversibly impair fertility. Patients with mild to moderate hepatic or renal dysfunction must use the medicine only under strict monitoring with reduced starting doses.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile of Seractiv (Dexibuprofen) is defined by official regulatory documents detailing substances that affect bleeding risk, drug exposure, and require timing restrictions. Co-administration with certain medicinal products is formally classified as a contraindication due to the increased potential for adverse outcomes.

Documented Pharmacodynamic and Contraindicated Combinations

Official labeling states that use is strictly restricted with other Non-steroidal Anti-inflammatory Drugs (NSAIDs), including COX-2 selective inhibitors, and Acetylsalicylic Acid (ASA) / Aspirin at high doses, due to an increased risk of gastrointestinal (GI) bleeding and ulceration. Pharmacodynamic interactions with Anticoagulants (e.g., Warfarin), Antiplatelet Agents, and SSRIs are documented to enhance the risk of bleeding. Furthermore, concurrent administration with Diuretics, ACE inhibitors, or ARBs may reduce their efficacy and elevate the risk of acute renal function impairment.

Pharmacokinetic and Timing-Based Constraints

Official documents describe Pharmacokinetic Interactions primarily via the CYP2C9 enzyme, where co-administration with CYP2C9 Inhibitors (e.g., Voriconazole) may increase Dexibuprofen plasma concentration. The clearance of co-administered drugs like Lithium and high-dose Methotrexate is also documented to be reduced, increasing their exposure. A mandatory timing separation is required when using Dexibuprofen with low-dose ASA for anti-platelet effect: the product must be taken at least 8 hours before or at least 30 minutes after the ASA. Food may reduce the rate of absorption, and alcohol use should be avoided due to the officially documented increased risk of GI bleeding.

Mechanism of Action

Targeted Inhibition of Cyclooxygenase (COX) Enzymes

The pharmacodynamic action of Seractiv (Dexibuprofen) is initiated by its chemical structure as the S(+)-enantiomer, which engages specific enzymes in the body. The action of Dexibuprofen involves the competitive and reversible inhibition of the Cyclooxygenase ( COX) enzymes, specifically both the COX-1 and COX-2 isoforms. This enzyme blockade prevents the catalytic conversion of arachidonic acid, which precedes the synthesis of physiological lipid mediators.

Modulating Prostaglandin Signaling

The direct result of COX inhibition is a systemic reduction in the production of prostaglandins—local lipid messengers—most notably PGE2. The decrease in these mediators alters two primary systems: it attenuates the chemical signals that sensitize peripheral nociceptors and it restricts the PGE2 signaling that raises the hypothalamic thermoregulatory set point.

Mechanistic Constraint and Non-Selective Action

A core aspect of this mechanism is its non-selective nature, meaning it influences the COX-1 enzyme responsible for homeostatic functions alongside the COX-2 enzyme involved in heightened responses. This constitutive enzyme modulation is a mechanistic constraint of its pharmacological class, as it reduces the basal level of prostaglandins that participate in processes such as gastric mucosal integrity and renal vascular regulation.

Dosage and Administration Information

How to Use Seractiv: Administration Guidelines

This section outlines the instructions for the use of Seractiv, which contains the active substance dexibuprofen.


Administration Scope

Instruction Category Usage Guidance
Route of Administration For oral use only.
Dosage Strengths Available as film-coated tablets in 200 mg, 300 mg, and 400 mg strengths.
Standard Dosing Regimen The typical daily dose ranges from 600 mg to 900 mg.
Maximum Dosing Limits The maximum single dose is 400 mg. The daily dose must not exceed 1200 mg.
Frequency and Timing The total daily dose is administered in divided doses up to three times per day.
Timing in Relation to Meals Tablets can be taken with or without a meal. Taking them with food is permitted to improve gastric tolerance, especially during longer courses of use.
Population-Specific Rules For older adults, treatment should be initiated at the lower end of the recommended dosage range. Patients with mild to moderate hepatic or renal impairment also require a reduced starting dose

Usage Protocol

Instructions structure the use of Seractiv as a protocol constrained by specific numeric limits and temporal guidelines. The medication is designated for the shortest duration possible at the lowest effective dose for symptom control. Procedurally, the initial dose is followed by subsequent doses in a divided manner, ensuring adherence to the 1200 mg maximum daily dose limit. The 200 mg and 400 mg tablets are scored, allowing them to be divided solely to facilitate easier ingestion.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Seractiv (Dexibuprofen)

Evidence from Clinical Trials for Osteoarthritis Pain

Research exploring the use of Seractiv for outcomes related to discomfort and functional measures associated with documented osteoarthritis primarily consists of short-term Randomized Controlled Trials (RCTs) and systematic reviews. These studies were applied in research contexts involving fluctuating or unstable symptoms in adult patients. Researchers used tools to measure patient-reported outcomes describing perceived discomfort and functional status, tracking how symptoms were observed to change in the study populations.

Studies report how symptoms evolved, and findings describe patterns observed in the studies related to outcomes linked to inflammatory or irritative states. However, what remains uncertain is that long-term outcomes are not well characterized in studies focused specifically on Seractiv beyond one year. Data for certain groups, such as those with complex joint issues, remain insufficient.


Studies Addressing Acute Pain Management

Seractiv was evaluated in research exploring how symptoms change over time when individuals experience an acute and disruptive episode of pain, such such as outcomes following minor surgical procedures. These trials were typically single-dose randomized, placebo-controlled studies applied in research settings of acute pain. Research examined outcomes related to physical discomfort, tracking measures like the time it took for patients to report the onset of change in pain intensity and the total reported change in intensity over a few hours.

Follow-up durations were limited, with most efficacy research focusing only on the immediate hours after a single dose. This means the results apply only to the specific acute scenario studied and provide limited information for long-term outcomes or how the study structure applies to sustained, multi-day symptom management.

Research for Primary Dysmenorrhea (Menstrual Cramps)

Seractiv was studied for conditions characterized by fluctuating or episodic manifestations, specifically for outcomes related to primary dysmenorrhea. Studies explored outcomes related to episodic or acute changes in pain intensity. Findings indicate patterns related to the reported onset of change in symptoms and the total change in intensity measured during the study period. Evidence quality varies across studies.


Evidence Gaps: What Remains Unclear in the Research

The research structure primarily addresses short-term and acute uses, but long-term outcomes are not fully established regarding outcomes related to long-term symptom management for chronic conditions. Comparative evidence is lacking for direct, long-term comparisons against all relevant therapeutic alternatives. Study results reflect the specific conditions under which they were conducted, and research provides context but not individual predictions regarding long-term response.

Key Studies & References

  1. Single dose oral dexibuprofen [S(+)-ibuprofen] for acute postoperative pain in adults
  2. Dexibuprofen – Application in Therapy and Current Clinical Research

Frequently Asked Questions (FAQ)

Common questions about Seractiv (FAQ)


Q: How quickly does Seractiv start working after you take it?

A: Official information regarding how the medicine works in the body suggests that the active substance reaches its highest concentration in the bloodstream approximately 2 to 5 hours after you take the tablet. The medicine may be absorbed more quickly if taken without food. This timeframe indicates when the highest level of the medicine is available to start affecting pain pathways.


Q: How long does one dose of Seractiv stay active in your system?

A: According to pharmacokinetic data, the amount of Seractiv in the body reduces by half (the elimination half-life) in roughly 1.8 to 3.5 hours. The substance's concentration significantly decreases over several hours, with official data indicating that it is largely cleared from the body within approximately 12 hours.


Q: Can Seractiv be taken with common over-the-counter pain relievers?

A: The official product information states that Seractiv, as a non-steroidal anti-inflammatory drug (NSAID), should not be used in combination with other NSAIDs, including high-dose Aspirin. This restriction is due to an increased risk of side effects. It is important to check the labels of other common over-the-counter pain relievers to ensure they are not also NSAIDs before combining them.


Q: Is it normal to feel a slight stomach upset when first starting Seractiv?

A: Official reports classify certain stomach issues as common reactions, meaning they occur in between 1 in 100 and 1 in 10 patients. These gastrointestinal disorders may include symptoms such as nausea, indigestion, or abdominal pain. Taking Seractiv with food may help improve tolerance for these effects.


Q: Does alcohol consumption affect how Seractiv works or increase side effects?

A: Official interaction warnings recommend that alcohol consumption should be avoided while using Seractiv. This is primarily due to an officially documented increased risk of serious gastrointestinal bleeding when the medicine is combined with alcohol.


Q: Can Seractiv cause changes in mood or sleep patterns?

A: Official side effect classifications list several effects related to the nervous system and psychological well-being. Common side effects include drowsiness, while uncommon or rare effects can include insomnia, anxiety, depression, and irritability. These effects are documented in official safety information.


Q: Are there any common supplements that should be avoided while on Seractiv?

A: Regulatory documents primarily focus on drug-drug interactions. However, official warnings note that combining Seractiv with certain herbal products, such as St. John's Wort, should be done with caution. This is because these products may have the potential to interact with the medication.


Q: Why is Seractiv sometimes prescribed instead of ibuprofen or naproxen?

A: Seractiv's active ingredient, Dexibuprofen, is the S(+) -enantiomer, which is the therapeutically active part of standard Ibuprofen. The isolation of this active component allows for a potentially lower milligram dose of the drug's active part. This difference in composition is the key factor that distinguishes it from the racemic mixture found in conventional ibuprofen products.


Q: What is the mechanism by which Seractiv reduces pain?

A: Seractiv works by reducing the body's production of chemical messengers called prostaglandins. It achieves this by causing a competitive and reversible inhibition of Cyclooxygenase ( COX) enzymes. Prostaglandins are key compounds that drive the processes of pain, fever, and inflammation throughout the body.


Q: Can Seractiv cause sensitivity to sunlight?

A: Yes, official regulatory documents list photosensitivity reactions (increased sensitivity to sunlight) as a very rare serious cutaneous adverse reaction (SCAR). Any skin reactions, especially severe ones, should be discussed with a healthcare professional.


Q: Is there a generic version of Seractiv available?

A: Seractiv is a specific brand name for the drug Dexibuprofen. While Seractiv may be marketed only under its specific brand name in certain regions, the active substance, Dexibuprofen, is available internationally under various product names. Due to the nature of the active substance, Dexibuprofen, non-branded versions may be available in some regions, but this varies by market.


Q: What are the signs of an allergic reaction to Seractiv?

A: The official patient leaflet provides examples of severe allergic reactions that require immediate medical attention. These signs can include difficulty breathing, swelling of the face or throat ( angioedema), a widespread skin rash, blistering, mucous membrane lesions, or chest pain.


Q: Are there any warnings about combining Seractiv with antidepressant medications?

A: Yes, regulatory documents specifically warn about interactions with Selective Serotonin Reuptake Inhibitors (SSRIs). Combining Seractiv with these types of antidepressant medications is documented to increase the risk of bleeding.


Q: Do different dosages of Seractiv have different side effect profiles?

A: Official warnings note that the risk of serious cardiovascular events, such as heart attack or stroke, is associated with high daily doses of Seractiv. This suggests that the severity of some adverse reactions may be related to the size of the dose being administered and the duration of use.


Q: What is the difference between Seractiv and a COX-2 inhibitor?

A: Seractiv is defined as a non-selective inhibitor, meaning it influences both COX-1 and COX-2 enzymes. In contrast, a COX-2 inhibitor primarily targets the COX-2 enzyme. The non-selective action of Seractiv is a fundamental part of its pharmacological class.


Q: Can Seractiv be used to treat migraines?

A: According to the official product summary of characteristics, migraine is not listed as one of the officially authorized therapeutic indications for which Seractiv has been specifically approved.


Q: What should I do if I miss a dose of Seractiv?

A: Official guidance in the patient leaflet states that if a dose is missed, the next dose should be taken at the regular scheduled time. It also states that a double dose should not be taken to compensate for the dose that was missed.


Q: Why might Seractiv cause fluid retention in some people?

A: Fluid retention and swelling ( oedema) have been officially reported in association with the use of non-steroidal anti-inflammatory drugs (NSAIDs) like Seractiv. This effect can occur because these products can sometimes affect the body's natural regulation of the kidneys and blood vessels.


Q: How is Seractiv eliminated from the body?

A: The majority of the active substance, Dexibuprofen, is eliminated from the body through the kidneys. This process is documented in the official pharmacokinetic data, which describes how the drug is processed and cleared from the system.


Q: Do children or teenagers ever use Seractiv for their conditions?

A: Official information states that Seractiv is generally established for use by adults, specifically those 18 years and older. The medicine is not recommended for children and adolescents because safety and efficacy have not been sufficiently established in those age groups.

How should Seractiv be stored and disposed of?

How to Store and Dispose of Seractiv?

The storage and disposal instructions for Seractiv (Dexibuprofen) are defined by official regulatory labeling to maintain the stability of the tablets and ensure environmental safety.


Mandatory Storage Conditions

Requirement Official Instruction
Temperature Limit Do not store above 25 °C.
Packaging Keep in the original ALU-PVC/PVDC blister packaging to preserve the 3-year shelf life.
Child Safety Keep this medicine out of the sight and reach of children.

Official Disposal Rules

For disposal, there are no special requirements for handling the unused product. However, regulatory guidelines mandate that the tablets must not be disposed of via wastewater or household waste to protect the environment. Patients are instructed to consult a pharmacist for correct, responsible disposal methods for unused or expired medicine.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Seractiv found in:

A-Z Index: